Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor antigens recognized by T lymphocytes.
Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Boon T, et al. Among authors: van den eynde b, van der bruggen p, van pel a. Annu Rev Immunol. 1994;12:337-65. doi: 10.1146/annurev.iy.12.040194.002005. Annu Rev Immunol. 1994. PMID: 8011285 Review.
A gene family named MAGE codes for antigens recognized by autologous CTL on a melanoma tumor. These genes are not expressed in normal tissues except for testis. ...
A gene family named MAGE codes for antigens recognized by autologous CTL on a melanoma tumor. These genes are not expressed in
CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation.
Carrasco J, Godelaine D, Van Pel A, Boon T, van der Bruggen P. Carrasco J, et al. Among authors: van pel a. Blood. 2006 Nov 1;108(9):2897-905. doi: 10.1182/blood-2005-11-007237. Epub 2006 Jul 20. Blood. 2006. PMID: 16857986
A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44.
Godelaine D, Carrasco J, Brasseur F, Neyns B, Thielemans K, Boon T, Van Pel A. Godelaine D, et al. Among authors: van pel a. Cancer Immunol Immunother. 2007 Jun;56(6):753-9. doi: 10.1007/s00262-006-0244-5. Epub 2006 Nov 10. Cancer Immunol Immunother. 2007. PMID: 17096150
Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities.
Connerotte T, Van Pel A, Godelaine D, Tartour E, Schuler-Thurner B, Lucas S, Thielemans K, Schuler G, Coulie PG. Connerotte T, et al. Among authors: van pel a. Cancer Res. 2008 May 15;68(10):3931-40. doi: 10.1158/0008-5472.CAN-07-5898. Cancer Res. 2008. PMID: 18483279 Free article.
Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.
Carrasco J, Van Pel A, Neyns B, Lethé B, Brasseur F, Renkvist N, van der Bruggen P, van Baren N, Paulus R, Thielemans K, Boon T, Godelaine D. Carrasco J, et al. Among authors: van pel a. J Immunol. 2008 Mar 1;180(5):3585-93. doi: 10.4049/jimmunol.180.5.3585. J Immunol. 2008. PMID: 18292586 Free article. Clinical Trial.
Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.
Lonchay C, van der Bruggen P, Connerotte T, Hanagiri T, Coulie P, Colau D, Lucas S, Van Pel A, Thielemans K, van Baren N, Boon T. Lonchay C, et al. Among authors: van pel a. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14631-8. doi: 10.1073/pnas.0405743101. Epub 2004 Sep 27. Proc Natl Acad Sci U S A. 2004. PMID: 15452345 Free PMC article.
Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide.
Godelaine D, Carrasco J, Lucas S, Karanikas V, Schuler-Thurner B, Coulie PG, Schuler G, Boon T, Van Pel A. Godelaine D, et al. Among authors: van pel a. J Immunol. 2003 Nov 1;171(9):4893-7. doi: 10.4049/jimmunol.171.9.4893. J Immunol. 2003. PMID: 14568970 Free article.
Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.
Coulie PG, Karanikas V, Lurquin C, Colau D, Connerotte T, Hanagiri T, Van Pel A, Lucas S, Godelaine D, Lonchay C, Marchand M, Van Baren N, Boon T. Coulie PG, et al. Among authors: van pel a. Immunol Rev. 2002 Oct;188:33-42. doi: 10.1034/j.1600-065x.2002.18804.x. Immunol Rev. 2002. PMID: 12445279 Review.
A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling.
Demotte N, Colau D, Ottaviani S, Godelaine D, Van Pel A, Boon T, van der Bruggen P. Demotte N, et al. Among authors: van pel a. Eur J Immunol. 2002 Jun;32(6):1688-97. doi: 10.1002/1521-4141(200206)32:6<1688::AID-IMMU1688>3.0.CO;2-9. Eur J Immunol. 2002. PMID: 12115652 Free article.
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, Brasseur F, Lethé B, Jotereau F, Boon T. Guilloux Y, et al. Among authors: van pel a. J Exp Med. 1996 Mar 1;183(3):1173-83. doi: 10.1084/jem.183.3.1173. J Exp Med. 1996. PMID: 8642259 Free PMC article.
A cytolytic T lymphocyte (CTL) clone that lyses many HLA-A2 melanomas was derived from a population of tumor-infiltrating lymphocytes of an HLA-A2 melanoma patient. ...Remarkably, the antigenic peptide recognized by the CTL is encoded by a sequence located in
A cytolytic T lymphocyte (CTL) clone that lyses many HLA-A2 melanomas was derived from a population of tumor-infiltrating lymp
73 results
Jump to page
Feedback